000 01348 a2200397 4500
005 20250517190047.0
264 0 _c20190802
008 201908s 0 0 eng d
022 _a1873-5576
024 7 _a10.2174/1568009618666171129145703
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAlessandrini, Lara
245 0 0 _aCancer Targeted Therapy Strategy: The Pathologist's Perspectives.
_h[electronic resource]
260 _bCurrent cancer drug targets
_c2018
300 _a410-420 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aNeoplasm Proteins
_xantagonists & inhibitors
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aPathologists
650 0 4 _aPrecision Medicine
650 0 4 _aPrognosis
700 1 _aPerin, Tiziana
700 1 _aKadare, Shahin
700 1 _aDel Pup, Lino
700 1 _aMemeo, Lorenzo
700 1 _aSteffan, Agostino
700 1 _aColarossi, Lorenzo
700 1 _aBerretta, Massimiliano
700 1 _aDe Paoli, Paolo
700 1 _aCanzonieri, Vincenzo
773 0 _tCurrent cancer drug targets
_gvol. 18
_gno. 5
_gp. 410-420
856 4 0 _uhttps://doi.org/10.2174/1568009618666171129145703
_zAvailable from publisher's website
999 _c27838655
_d27838655